Evidence map›Paper›PMID 30996297›Full record

ArticleScientific reports2019

Loss of PKM2 in Lgr5

Yeji Kim, Yong-Soo Lee, Sung Wan Kang, Seungil Kim, Tae-Young Kim, Su-Hyun Lee, Sung Wook Hwang, Jihun Kim, Eun Na Kim, Jin-Sung Ju and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Prognostic Value of PKM2 Expression in de novo Metastatic Colorectal Cancer Patients.Asian Pacific journal of cancer prevention : APJCP · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. ROS signaling-induced mitochondrial Sgk1 expression regulates epithelial cell renewal.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yeji KimMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Yong-Soo LeeMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Sung Wan KangMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Seungil KimMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Tae-Young KimMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Su-Hyun LeeMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Sung Wook HwangDepartment of Gastroenterology, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Jihun KimDepartment of Pathology, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Eun Na KimDepartment of Pathology, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Jin-Sung JuDepartment of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Yun-Yong ParkDepartment of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea. yypark@amc.seoul.kr.
Mi-Na KweonMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea. mnkweon@amc.seoul.kr.
Asan Medical Center · KRUlsan College · KRUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regulatory properties of pyruvate kinase M2 isoform (PKM2), the key glycolytic enzyme, influence altered energy metabolism including glycolysis in cancer. In this study, we found that PKM2 was highly expressed in patients with ulcerative colitis or colorectal cancer (CRC). We then investigated the effectiveness of conditionally ablating PKM2 in Lgr5

Indexed as

AnimalsCarrier ProteinsCells, CulturedCell Transformation, NeoplasticCohort StudiesColitis, UlcerativeColorectal NeoplasmsDisease Models, AnimalHumansIntestinesMaleMembrane ProteinsMicePyruvate KinaseReceptors, G-Protein-CoupledStem CellsCarrier ProteinsLGR5 protein, humanLgr5 protein, mouseMembrane ProteinsPkm protein, mousePyruvate KinaseReceptors, G-Protein-CoupledTamoxifenThyroid Hormone-Binding ProteinsThyroid Hormones

Identifiers

PMID30996297
PMCPMC6470145
OpenAlexW2938949785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.